Key Developments: ResMed Inc (RMD.N)
48.38USD
1 Aug 2013
$0.73 (+1.53%)
$47.65
$48.50
$49.41
$47.90
522,336
238,662
$51.39
$31.08
Latest Key Developments (Source: Significant Developments)
ResMed Inc Declares Quarterly Dividend
ResMed Inc announced that the Board of Directors has declared a quarterly dividend of $0.25 per share, which will have a record date of August 20, 2013, and be payable on September 17, 2013. Full Article
ResMed Inc Succeeds in Patent Fight Against APEX Medical Corp
ResMed Inc announced that a U.S. government investigation started at the request of ResMed against Taiwanese manufacturer APEX Medical Corp. has resulted in an administrative law judge at the International Trade Commission (ITC) determining that the ITC should enter a consent decree against APEX stopping the importation and sale of infringing APEX products. ResMed is a global innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions. The original action, filed by ResMed in March 2013 with the ITC, asserted patent infringement by two APEX masks and two APEX flow generators: the APEX WiZARD 210 and WiZARD 220 masks; and the APEX iCH and XT Fit flow generators. The ITC case against APEX also named Medical Depot, Inc., doing business as Drive Medical Design and Manufacturing (Drive). The same ITC administrative law judge previously determined that the ITC should enter a consent decree against Drive thereby ordering it to stop importation and sales of the Freedom 210 and Freedom 220 masks made by APEX, which are identical to the WiZARD masks. Full Article
Resmed Inc Declares Quarterly Dividend
Resmed Inc announced that it declared a quarterly dividend of $0.17 per share, which will have a record date of May 21, 2013, and be payable on June 18, 2013. Full Article
Resmed Inc Files Lawsuit Against Apex Medical Corp
Apex Medical Corp (Apex) announced that Resmed Inc filed a lawsuit against Apex in California Central District Court, alleging Apex's infringement of its patent right. Details were not disclosed. Full Article
Resmed Inc Announces Changes In Board Of Directors
Resmed Inc announced that effective March 1, 2013, Michael (Mick) Farrell will succeed Dr. Peter C. Farrell as ResMed's chief executive officer (CEO) and be appointed to its board of directors. Robert (Rob) Douglas will become ResMed's president and chief operating officer (COO). Current CEO, chairman of the board and founder, Dr. Farrell, will become executive chairman. Full Article
Resmed Inc Declares Quarterly Dividend
Resmed Inc announced that Board of Directors has declared a quarterly dividend of $0.17 per share, which will have a record date of February 19, 2013, and be payable on March 19, 2013. Full Article
Resmed Inc Declares Quarterly Dividend
Resmed Inc announced that the Board of Directors has today declared a quarterly dividend of $0.17 per share, which will have a record date of November 20, 2012, and be payable on December 18, 2012. Full Article
ResMed Inc. Declares Quarterly Dividend
ResMed Inc. announced that its Board of Directors have declared a quarterly dividend of $0.17 per share, which will have a record date of September 7, 2012, and be payable on September 28, 2012. Full Article
ResMed Inc. Announces Holding Interest Of Perpetual Limited
ResMed Inc. announced that Perpetual Limited has an interest of 78,850,607 ordinary shares, representing 5.07% of the voting power in the Company. Full Article
ResMed Inc. Announces Holding Interest Of JCP Investment Partners Ltd
ResMed Inc. announced that JCP Investment Partners Ltd is holding an interest of 78,431,898 ordinary shares, representing 5.04% of voting power in the Company. Full Article

Earnings vs.
Estimates